Study of Fixed-Dose Combinations of Trabodenoson and Latanoprost in Adults With OHT or POAG

Clinical trial NCT02829996 · COMPLETED

Trial details

NCT number: NCT02829996
Sponsor: Inotek Pharmaceuticals Corporation
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Primary Open-Angle Glaucoma (POAG)Ocular Hypertension (OHT)

Start date: 2016-08-19
Primary completion: 2017-05-24
Enrollment: 201

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.